/Investors

Invus — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Kronos Biokronosbio.cominAug 2020 · $155M

BiotechNew York, US

Norbert Bischofberger, Ph.D.(Executive Officer, Director)Christopher Wilfong(Executive Officer)

BoardRebecka Belldegrun, M.D.(Director)Otello Stampacchia, Ph.D.(Director)David M. Tanen(Executive Officer, Director, Promoter)Arie S. Belldegrun, M.D.(Director)

Co-investorsEcoR1 CapitalGV (Google Ventures)Nextech InvestVida VenturesBlackRockCommodore Capital+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

iTeos TherapeuticsTalaris Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.